Skip to Main Content

Paper Details

Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastoma.
Neurooncol Adv
2
2022
RNA, SHH, SHH medulloblastoma, SMO, Selinexor, Smoothened, Sonidegib, Sonidegib-sensitive and -resistant lines, human, medulloblastoma, patient, patient-derived xenograft, patients, resistant line, resistant lines, resistant models, sensitive models, sonic hedgehog, tumors
Author NameAffiliation
Sebastian BrabetzPreclinical Pediatric Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ)
Sebastian BrabetzHeidelberg University
Sebastian BrabetzGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Sebastian BrabetzPreclinical Pediatric Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ)
Sebastian BrabetzGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Sebastian BrabetzHeidelberg University
Laura SieberPreclinical Pediatric Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ)
Laura SieberGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Andrey KorshunovPreclinical Pediatric Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ)
Andrey KorshunovInstitute of Pathology, University Hospital Heidelberg and Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ)
Andrey KorshunovPreclinical Pediatric Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ)
Andrey KorshunovInstitute of Pathology, University Hospital Heidelberg and Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ)
Natalie J??gerPreclinical Pediatric Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ)
Natalie J??gerGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Natalie J??gerPreclinical Pediatric Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ)
Natalie J??gerGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Olaf WittPreclinical Pediatric Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ)
Olaf WittHeidelberg University Hospital
Olaf WittClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ)
Olaf WittPreclinical Pediatric Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ)
Olaf WittClinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ)
Olaf WittHeidelberg University Hospital
Stefan M PfisterPreclinical Pediatric Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterHeidelberg University Hospital
Stefan M PfisterGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Stefan M PfisterPreclinical Pediatric Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Stefan M PfisterHeidelberg University Hospital
Marcel KoolPreclinical Pediatric Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ)
Marcel KoolGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Marcel KoolPreclinical Pediatric Oncology, Hopp Children's Cancer Center Heidelberg (KiTZ)
Marcel KoolGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
  • 1 - 34

Datasets